Related Experiment Video
Updated: Aug 11, 2026
10:17
The Tail Suspension Test
Published on: January 28, 2012
Effect of lithium on norepinephrine metabolic pathways
E Sastre1, A Nicolay, B Bruguerolle
1Laboratoire de Chimie Analytique, Faculté de Pharmacie, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 5, France. elisabeth.sastre@pharmacie.univ-mrs.fr
Life Sciences
|June 7, 2005
Summary
Lithium treatment in rats altered norepinephrine (NE) breakdown pathways, favoring a specific route (way A). This suggests lithium may reduce available NE for adrenergic receptors.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Norepinephrine (NE) is a key neurotransmitter involved in various physiological processes.
- Understanding NE catabolism is crucial for comprehending its role in neurological functions and the effects of pharmacological interventions.
- Lithium is a mood-stabilizing drug with known effects on neurotransmitter systems.
Purpose of the Study:
- To investigate the impact of lithium on the metabolic pathways of norepinephrine (NE) in rats.
- To quantify NE and its metabolites, 3-methoxy-4-hydroxyphenylglycol (MHPG) and 3,4-dihydroxyphenyl glycol (DHPG), under lithium treatment.
- To examine the influence of lithium on ion levels (Li+, Mg2+, K+) in plasma and cerebral cortex.
Main Methods:
- Rats were administered lithium chloride or sodium chloride (control).
- Plasma and cerebral cortex samples were analyzed using High-Performance Liquid Chromatography (HPLC) with electrochemical detection.
- Measurements included norepinephrine (NE), MHPG, DHPG, and ions (Li+, Mg2+, K+) at various time points over six hours.
Main Results:
- Lithium treatment led to preferential catabolism of NE via pathway A (without DHPG) in both plasma and cerebral cortex.
- Lithium administration resulted in increased plasma levels of magnesium (Mg2+) and potassium (K+).
Conclusions:
- Lithium appears to enhance the inactivation of norepinephrine (NE).
- This enhanced inactivation may lead to a decrease in the availability of NE for adrenergic receptors.
- Findings suggest a specific mechanism by which lithium influences noradrenergic neurotransmission.
Related Concept Videos
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...